All Study Guides Intro to Pharmacology Unit 3
💊 Intro to Pharmacology Unit 3 – Pharmacokinetics: Drug ADME ProcessesPharmacokinetics is all about how your body handles drugs. It's like tracking a drug's journey from the moment it enters your system to when it leaves. This process involves four key steps: absorption, distribution, metabolism, and excretion (ADME).
Understanding ADME helps doctors figure out the right dose and timing for medications. It's crucial for making sure drugs work effectively and safely. Factors like age, weight, and overall health can affect how your body processes drugs, so it's not a one-size-fits-all deal.
What's Pharmacokinetics Anyway?
Pharmacokinetics (PK) describes how the body processes a drug
Involves the journey of a drug from administration to elimination
Includes four main processes: absorption, distribution, metabolism, and excretion (ADME)
Helps determine the appropriate dose, route, and frequency of drug administration
Plays a crucial role in understanding drug efficacy, safety, and potential interactions
Pharmacokinetic principles apply to various drug formulations (oral, intravenous, topical)
Considers factors such as age, weight, gender, and disease states that influence drug processing
The ADME Lowdown
ADME stands for Absorption, Distribution, Metabolism, and Excretion
Represents the four key processes that a drug undergoes in the body
Absorption involves the drug entering the bloodstream from the site of administration
Distribution describes the drug's journey to various tissues and organs
Metabolism refers to the chemical modification of the drug by enzymes, primarily in the liver
Excretion is the removal of the drug and its metabolites from the body
Understanding ADME helps predict drug behavior and optimize therapeutic outcomes
Absorption: Getting Drugs into Your System
Absorption is the process by which a drug enters the bloodstream
Occurs at various sites depending on the route of administration (oral, intravenous, intramuscular)
Factors influencing absorption include drug formulation, pH, and gastrointestinal motility
Bioavailability refers to the fraction of the administered dose that reaches the systemic circulation
Oral drugs often have lower bioavailability due to first-pass metabolism in the liver
Intravenous administration results in 100% bioavailability
Absorption rate and extent can be modified by drug formulation techniques (extended-release, enteric coating)
Food and other medications can affect absorption by altering gastrointestinal pH or motility
Diseases affecting gastrointestinal function (Crohn's disease, celiac disease) can impact drug absorption
Distribution: Drugs on Tour in Your Body
Distribution refers to the movement of a drug from the bloodstream to various tissues and organs
Depends on factors such as blood flow, tissue permeability, and protein binding
Drugs bind to plasma proteins (albumin, alpha-1-acid glycoprotein), affecting their distribution
Highly protein-bound drugs (warfarin) have limited distribution to tissues
Drugs with low protein binding (acetaminophen) distribute more readily
Some drugs accumulate in specific tissues (fat-soluble drugs in adipose tissue, bone-seeking agents)
Distribution can be influenced by disease states that alter protein levels or tissue permeability
The volume of distribution (Vd) is a measure of the extent of drug distribution in the body
Calculated as: V d = A m o u n t o f d r u g i n t h e b o d y / P l a s m a d r u g c o n c e n t r a t i o n Vd = Amount of drug in the body / Plasma drug concentration V d = A m o u n t o fd r ug in t h e b o d y / Pl a s ma d r ug co n ce n t r a t i o n
Drugs with high Vd (digoxin) distribute widely, while those with low Vd (gentamicin) remain primarily in the bloodstream
Metabolism is the chemical modification of a drug by enzymes, primarily in the liver
Converts drugs into more water-soluble compounds (metabolites) for easier excretion
Cytochrome P450 (CYP) enzymes play a significant role in drug metabolism
Genetic variations in CYP enzymes can lead to interindividual differences in drug response
Some drugs (rifampin) induce CYP enzymes, while others (grapefruit juice) inhibit them
Phase I metabolism involves oxidation, reduction, or hydrolysis reactions
Phase II metabolism involves conjugation reactions (glucuronidation, sulfation)
Metabolism can result in the formation of active, inactive, or toxic metabolites
Factors affecting metabolism include age, liver function, and concomitant medications
Understanding metabolism helps predict drug interactions and adjust dosages in liver impairment
Excretion: The Final Exit
Excretion is the removal of a drug and its metabolites from the body
Primary routes of excretion include renal (kidneys), biliary (liver), and pulmonary (lungs)
Renal excretion involves glomerular filtration, tubular secretion, and tubular reabsorption
Drugs that are highly protein-bound (aspirin) undergo less glomerular filtration
Some drugs (penicillins) are actively secreted into the tubular lumen
Biliary excretion involves the transport of drugs from the liver into the bile
Drugs excreted in the bile (rifampin) may undergo enterohepatic recirculation
Pulmonary excretion is significant for volatile anesthetics and alcohol
The elimination half-life (t1/2) is the time required for the plasma concentration to decrease by 50%
Calculated as: t 1 / 2 = 0.693 × V d / C l e a r a n c e t1/2 = 0.693 × Vd / Clearance t 1/2 = 0.693 × V d / Cl e a r an ce
Clearance is the volume of plasma cleared of a drug per unit time
Factors affecting excretion include renal and hepatic function, urine pH, and drug-drug interactions
Factors That Mess with ADME
Age: Infants and the elderly may have altered ADME due to differences in organ function and body composition
Genetics: Polymorphisms in drug-metabolizing enzymes (CYP2D6) can lead to poor or ultra-rapid metabolism
Disease states: Renal impairment, liver dysfunction, and cardiovascular disease can affect ADME processes
Drug-drug interactions: Concomitant medications can induce or inhibit drug-metabolizing enzymes or transporters
Inducers (rifampin) increase enzyme activity, leading to reduced drug exposure
Inhibitors (ketoconazole) decrease enzyme activity, leading to increased drug exposure
Food and herb-drug interactions: Certain foods (grapefruit juice) and herbal products (St. John's Wort) can alter drug ADME
Pregnancy: Physiological changes during pregnancy can impact drug ADME and necessitate dose adjustments
Obesity: Altered body composition and organ function in obesity can affect drug distribution and clearance
Why This Stuff Matters in Real Life
Understanding ADME helps optimize drug therapy by selecting appropriate doses and routes of administration
Pharmacokinetic principles guide dose adjustments in special populations (pediatrics, geriatrics, renal impairment)
Knowledge of ADME is crucial for managing drug interactions and avoiding adverse effects
Pharmacokinetic studies are essential in drug development to determine dosing regimens and formulation strategies
Therapeutic drug monitoring (TDM) relies on pharmacokinetic principles to ensure drug concentrations are within the therapeutic range
TDM is particularly important for drugs with narrow therapeutic indices (aminoglycosides, antiepileptics)
Personalized medicine utilizes pharmacokinetic data to tailor drug therapy based on individual patient characteristics
Understanding ADME helps healthcare professionals educate patients on proper drug use and adherence